Cargando…
Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing
Targeted therapies and, more precisely, EGFR tyrosine kinase inhibitors (TKIs) have been a major improvement in the therapeutic management of EGFR-mutated non-small-cell lung cancers (NSCLCs). Earlier administration of these TKIs throughout tumor progression is imperative to improve patient outcomes...
Autores principales: | Billaud, Amandine, Verriele, Veronique, Dauvé, Jonathan, Chevalier, Louise-Marie, Morel, Alain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460542/ https://www.ncbi.nlm.nih.gov/pubmed/32751202 http://dx.doi.org/10.3390/diagnostics10080527 |
Ejemplares similares
-
DISSECT Method Using PNA-LNA Clamp Improves Detection of EGFR T790m Mutation
por: Guha, Minakshi, et al.
Publicado: (2013) -
Kir2.2 p.Thr140Met: a genetic susceptibility to sporadic periodic paralysis
por: FAN, CHUNXIANG, et al.
Publicado: (2018) -
Myocardial Infarction and AGT p.Thr174Met Polymorphism: A Meta-Analysis of 7657 Subjects
por: Li, Yan-yan, et al.
Publicado: (2021) -
Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping
por: Kim, Hye-Ryoun, et al.
Publicado: (2013) -
CACNA1A-p.Thr501Met mutation associated with familial hemiplegic migraine: a family report
por: Romozzi, Marina, et al.
Publicado: (2021)